New Data on HPV Infections Could Lead to Programs to Reduce Cancer Incidence

Human papillomavirus (HPV) encompasses over 200 viruses, many spreading through sexual contact.  Twelve strains of HPV are considered “high-risk HPV,” and these variants can cause cancer.  Alternately, “low-risk HPV” strains can cause less severe health conditions, like warts.  HPVs cause one of the most highly transmitted sexually transmitted infections, leading to millions of cases of… Continue reading New Data on HPV Infections Could Lead to Programs to Reduce Cancer Incidence

Hold Up, HPV: How Therapeutic Vaccines Can Help Curb Cervical Premalignancies

Since their adoption nearly 20 years ago, preventive human papilloma virus (HPV) vaccines have dramatically reduced the rates of HPV infection and cervical precancers, especially in young women. Despite our progress, almost 14,000 new cases of cervical cancer are still diagnosed each year in the United States, and almost all are linked to HPV.  However,… Continue reading Hold Up, HPV: How Therapeutic Vaccines Can Help Curb Cervical Premalignancies

[News] India is boosting vaccination efforts to eradicate cervical cancer

A new initiative, led by the Indian Medical Association (IMA) and the Federation of Obstetric and Gynaecological Societies of India (FOGSI), seeks to eliminate cervical cancer in India. As part of the initiative, a massive training programme is underway, which aims to train more than 50 000 physicians across India to help fight cervical cancer through… Continue reading [News] India is boosting vaccination efforts to eradicate cervical cancer

The role of human leukocyte antigen in HTLV-1 infection and progression to ATLL and HAM/TSP: a systematic review and meta-analysis

Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that leads to lifelong infection and multiple diseases, including HAM/TSP and ATLL. Despite extensive research, the exact pathophysiology of HTLV… Continue reading on BioMed Central